Leveraging precision medicine and eHealth to predict cancer predisposition syndromes in children: A Canadian initiative to redress global health disparities in cancer genetics

利用精准医学和电子健康来预测儿童癌症易感综合症：加拿大旨在纠正癌症遗传学方面全球健康差异的一项举措

• 批准号: 479489
• 负责人: Goudie Catherine
• 金额: $ 51.27万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-03-01 至 2028-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=479489&lang=en
• 关键词: Cancer; Cancer Predisposition Syndrome; Clinical Utility; Ehealth; Ethics; Genetics; Global Health; Liability; Pediatrics; Prediction Models

Cancer predisposition syndromes (CPSs) are genetic conditions that increase the risk of developing one or more cancers over a lifetime. There are more than 50 CPSs known to cause cancer in children. When a CPS is diagnosed, doctors can start tumor surveil

癌症易感综合征（CPS）是一种遗传性疾病，会增加一生中患一种或多种癌症的风险。已知有50多种CPS会导致儿童癌症。当CPS被诊断出来时，医生可以开始肿瘤监测，